Dihexa Peptide: Cognitive Research and Safety Status | telos rx
girl reading book
← Back to blog
cognitive

Dihexa Peptide: Cognitive and Synaptic Research Overview

By TelosRX Editorial Team Updated

Dihexa is a hexapeptide derivative studied in cognitive and synaptic plasticity research. This page is an educational overview. telos rx does not offer or prescribe dihexa.

What Is Dihexa?

Dihexa is a small peptide derivative of angiotensin IV. It is studied in preclinical research for synaptic and cognitive pathways.

Dihexa is not an FDA-approved drug.

Where Dihexa Shows Up in Research

Dihexa comes up most often in research on:

  • Cognitive performance
  • Synaptic plasticity
  • Neurotrophic pathways
  • Memory

This work is laboratory and animal research. FDA has stated that it has not identified any human exposure data for drug products containing dihexa, so its safety in people is unknown.

Regulatory Context

Dihexa is not FDA-approved. It was not among the peptides reviewed by the FDA's Pharmacy Compounding Advisory Committee in July 2026, and it is not covered by the interim enforcement discretion policy HHS announced on October 28, 2026, which applies only to BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500.

Does telos rx Offer Dihexa?

No. telos rx does not offer, prescribe or ship dihexa.

Important Information

Dihexa is not FDA-approved. This article is for education only and is not medical advice.

Want to read more? Browse our Peptide Research blog.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX